{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:00:48Z","timestamp":1790694048824,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005356","name":"Zhejiang Shuren University","doi-asserted-by":"publisher","award":["2022-318"],"award-info":[{"award-number":["2022-318"]}],"id":[{"id":"10.13039\/501100005356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202511842002"],"award-info":[{"award-number":["202511842002"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.isci.2026.115154","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:30:22Z","timestamp":1773246622000},"page":"115154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the lethal weakness of SFTSV: Latest advances in antiviral strategies and immune prevention"],"prefix":"10.1016","volume":"29","author":[{"given":"Ruiqi","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keda","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115154_bib1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study","volume":"18","author":"Li","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115154_bib3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/infdis\/jit603","article-title":"The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan","volume":"209","author":"Takahashi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3201\/eid2411.170756","article-title":"Severe Fever with Thrombocytopenia Syndrome Virus Infection, South Korea, 2010","volume":"24","author":"Kim","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib5","article-title":"The First Nationwide Surveillance of Severe Fever with Thrombocytopenia Syndrome in Ruminants and Wildlife in Taiwan","volume":"15","author":"Kuan","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib6","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/cid\/cir732","article-title":"A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission","volume":"53","author":"Bao","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib7","doi-asserted-by":"crossref","DOI":"10.3201\/eid2409.171427","article-title":"World Health Organization Methodology to Prioritize Emerging Infectious Diseases in Need of Research and Development","volume":"24","author":"Mehand","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/1040841X.2020.1847037","article-title":"Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus","volume":"47","author":"Li","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib9","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1080\/15548627.2021.1994296","article-title":"Bunyavirus SFTSV exploits autophagic flux for viral assembly and egress","volume":"18","author":"Yan","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.isci.2026.115154_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00302-23","article-title":"The SFTSV Nonstructural Proteins Induce Autophagy to Promote Viral Replication via Interaction with Vimentin","volume":"97","author":"Liu","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115154_bib11","article-title":"CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.115154_bib12","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1038\/s41467-025-59305-0","article-title":"Genome-wide CRISPR screening identifies LRP1 as an entry factor for SFTSV","volume":"16","author":"Xing","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115154_bib13","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1038\/s44319-024-00310-7","article-title":"Severe fever with thrombocytopenia syndrome virus induces lactylation of m6A reader protein YTHDF1 to facilitate viral replication","volume":"25","author":"Liu","year":"2024","journal-title":"EMBO Rep."},{"key":"10.1016\/j.isci.2026.115154_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI129171","article-title":"Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections","volume":"130","author":"Suzuki","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.115154_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/infdis\/jiae039","article-title":"Identification of CCL20 as a Prognostic Predictor for Severe Fever With Thrombocytopenia Syndrome Based on Plasma Proteomics","volume":"230","author":"Zhang","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102131","article-title":"Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis","volume":"46","author":"Wu","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.115154_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02628-24","article-title":"A global lipid map of severe fever with thrombocytopenia syndrome virus infection reveals glycerophospholipids as novel prognosis biomarkers","volume":"15","author":"Tian","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.isci.2026.115154_bib18","article-title":"Investigation into the Pancreatic Pathogenesis of SFTSV across Multiple Levels","volume":"13","author":"Liu","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.115154_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41564-022-01279-6","article-title":"Akkermansia muciniphila protects mice against an emerging tick-borne viral pathogen","volume":"8","author":"Xie","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib20","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cid\/cit530","article-title":"Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome","volume":"57","author":"Liu","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009103","article-title":"A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome","volume":"15","author":"Suemori","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12462","article-title":"Ruxolitinib for severe fever with thrombocytopenia syndrome (SFTS)","volume":"8","author":"Wen","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.isci.2026.115154_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012216","article-title":"Identification and characterization of three monoclonal antibodies targeting the SFTSV glycoprotein and displaying a broad spectrum recognition of SFTSV-related viruses","volume":"18","author":"Wu","year":"2024","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107120","article-title":"Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19","volume":"90","author":"Xia","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.115154_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijid.2023.03.015","article-title":"Clinical efficacy of low-dose glucocorticoid therapy for critically ill patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study","volume":"130","author":"Wang","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012411","article-title":"Recent research advances in the development of Dabie Banda virus vaccines","volume":"18","author":"Yu","year":"2024","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib27","doi-asserted-by":"crossref","first-page":"26900","DOI":"10.1073\/pnas.1914704116","article-title":"Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model","volume":"116","author":"Yu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.115154_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12121403","article-title":"Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus","volume":"12","author":"Hicks","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2026.115154_bib29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.115154_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41541-024-01061-1","article-title":"Haemaphysalis longicornis subolesin controls the infection and transmission of severe fever with thrombocytopenia syndrome virus","volume":"10","author":"Yuan","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.115154_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh2264","article-title":"Lrp1 is essential for lethal Rift Valley fever hepatic disease in mice","volume":"9","author":"Schwarz","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2026.115154_bib32","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/nar\/gkac1249","article-title":"Structural insights into viral genome replication by the severe fever with thrombocytopenia syndrome virus L protein","volume":"51","author":"Williams","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.115154_bib33","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1093\/nar\/gkae330","article-title":"Structural snapshots of phenuivirus cap-snatching and transcription","volume":"52","author":"Williams","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.115154_bib34","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.chembiol.2024.10.009","article-title":"Host specific sphingomyelin is critical for replication of diverse RNA viruses","volume":"31","author":"Han","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2026.115154_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012725","article-title":"N6-methyladenosine RNA modification promotes Severe Fever with Thrombocytopenia Syndrome Virus infection","volume":"20","author":"Chen","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.115154_bib36","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1080\/15548627.2025.2503564","article-title":"SFTSV induces liver ferroptosis through m6A-related ferritinophagy","volume":"21","author":"Liu","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.isci.2026.115154_bib37","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jtha.2023.02.006","article-title":"Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation","volume":"21","author":"Fang","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.isci.2026.115154_bib38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41564-018-0317-1","article-title":"Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis","volume":"4","author":"Park","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41564-019-0390-0","article-title":"Ferreting out viral pathogenesis","volume":"4","author":"Wuerth","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib40","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1080\/15548627.2024.2356505","article-title":"Bunyavirus SFTSV NSs utilizes autophagy to escape the antiviral innate immune response","volume":"20","author":"Li","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.isci.2026.115154_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013201","article-title":"SFTSV NSs degrades SAFA via autophagy to suppress SAFA-dependent antiviral response","volume":"21","author":"Yu","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.115154_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/15548627.2024.2393067","article-title":"Bunyavirus SFTSV nucleoprotein exploits TUFM-mediated mitophagy to impair antiviral innate immunity","volume":"21","author":"Zhang","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.isci.2026.115154_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03796-23","article-title":"SFTSV nucleoprotein mediates DNA sensor cGAS degradation to suppress cGAS-dependent antiviral responses","volume":"12","author":"Jiang","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2026.115154_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01815-23","article-title":"Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-\u03baB signaling pathway","volume":"98","author":"Jia","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115154_bib45","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1038\/s41564-024-01801-y","article-title":"Taurolithocholic acid protects against viral haemorrhagic fever via inhibition of ferroptosis","volume":"9","author":"Zheng","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011158","article-title":"A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study","volume":"17","author":"Xia","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2015.04.006","article-title":"Common adverse events associated with ribavirin therapy for Severe Fever with Thrombocytopenia Syndrome","volume":"119","author":"Lu","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2026.115154_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-021-00541-3","article-title":"Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.115154_bib49","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1128\/JVI.00612-12","article-title":"Suppression of the interferon and NF-\u03baB responses by severe fever with thrombocytopenia syndrome virus","volume":"86","author":"Qu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115154_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12985-015-0412-3","article-title":"Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection","volume":"12","author":"Shimojima","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.isci.2026.115154_bib51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12916-022-02558-z","article-title":"Antiviral activity and mechanism of the antifungal drug, anidulafungin, suggesting its potential to promote treatment of viral diseases","volume":"20","author":"Shen","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.isci.2026.115154_bib52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12916-024-03421-z","article-title":"Ruxolitinib plus standard of care in severe hospitalized adults with severe fever with thrombocytopenia syndrome (SFTS): an exploratory, single-arm trial","volume":"22","author":"Wen","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.isci.2026.115154_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00015-23","article-title":"Calcium Influx Regulates the Replication of Several Negative-Strand RNA Viruses Including Severe Fever with Thrombocytopenia Syndrome Virus","volume":"97","author":"Urata","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115154_bib54","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","article-title":"Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality","volume":"29","author":"Li","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2026.115154_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virs.2022.01.014","article-title":"Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus","volume":"37","author":"Yang","year":"2022","journal-title":"Virol. Sin."},{"key":"10.1016\/j.isci.2026.115154_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01399-24","article-title":"Efficacy of CP-COV03 (a niclosamide-based inorganic nanohybrid product) against severe fever with thrombocytopenia syndrome virus in an in vitro model","volume":"12","author":"Han","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2026.115154_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/v16081332","article-title":"Antiviral Activity of Selective Estrogen Receptor Modulators against Severe Fever with Thrombocytopenia Syndrome Virus In Vitro and In Vivo","volume":"16","author":"Yan","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/v11040385","article-title":"Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome Virus","volume":"11","author":"Yuan","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib59","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.virs.2024.08.007","article-title":"Antiviral activity of vitamin D derivatives against severe fever with thrombocytopenia syndrome virus in vitro and in vivo","volume":"39","author":"Luo","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.isci.2026.115154_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.106004","article-title":"M\u03b2CD inhibits SFTSV entry by disrupting lipid raft structure of the host cells","volume":"231","author":"Cheng","year":"2024","journal-title":"Antiviral Res."},{"key":"10.1016\/j.isci.2026.115154_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/v15040940","article-title":"Recent Advances in the Study of the Immune Escape Mechanism of SFTSV and Its Therapeutic Agents","volume":"15","author":"Chen","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijid.2013.08.011","article-title":"Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome","volume":"18","author":"Oh","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.115154_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/v14081665","article-title":"Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal Model","volume":"14","author":"Shimojima","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103591","article-title":"Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome","volume":"72","author":"Yuan","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.115154_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00294-7","article-title":"Potential efficacy of existing drug molecules against severe fever with thrombocytopenia syndrome virus: an in silico study","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115154_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/v15091963","article-title":"Non-Structural Protein-W61 as a Novel Target in Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV): An In-Vitro and In-Silico Study on Protein-Protein Interactions with Nucleoprotein and Viral Replication","volume":"15","author":"Park","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/v13102047","article-title":"In Silico Structure-Based Design of Antiviral Peptides Targeting the Severe Fever with Thrombocytopenia Syndrome Virus Glycoprotein Gn","volume":"13","author":"Yuan","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fmicb.2020.00150","article-title":"Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection","volume":"11","author":"Takayama-Ito","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib70","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fimmu.2019.01182","article-title":"Interferon-\u03b3-Directed Inhibition of a Novel High-Pathogenic Phlebovirus and Viral Antagonism of the Antiviral Signaling by Targeting STAT1","volume":"10","author":"Ning","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115154_bib71","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1038\/s41467-024-51108-z","article-title":"A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection","volume":"15","author":"Ren","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115154_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105481","article-title":"Discovery and characterization of potent broadly neutralizing antibodies from human survivors of severe fever with thrombocytopenia syndrome","volume":"111","author":"Zhang","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.115154_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007375","article-title":"An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus","volume":"15","author":"Kim","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.115154_bib74","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1705176114","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.115154_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012550","article-title":"Molecular mechanism and structure-guided humanization of a broadly neutralizing antibody against SFTSV","volume":"20","author":"Yang","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.115154_bib76","article-title":"Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge","volume":"21","author":"Li","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.115154_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113735","article-title":"The therapeutic potential of mRNA-encoded SFTSV human monoclonal antibody encapsulated lipid nanoparticle in vivo","volume":"382","author":"Lee","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.115154_bib78","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijid.2022.06.058","article-title":"Tocilizumab therapy for IL-6 increment in a patient with non-fatal severe fever with thrombocytopenia syndrome","volume":"122","author":"Yoo","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106181","article-title":"Effect of tocilizumab plus corticosteroid on clinical outcome in patients hospitalized with severe fever with thrombocytopenia syndrome: A randomized clinical trial","volume":"89","author":"Ge","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.isci.2026.115154_bib80","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1016\/j.cell.2024.09.043","article-title":"Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy","volume":"187","author":"Xiang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.115154_bib81","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s44321-024-00026-0","article-title":"Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody","volume":"16","author":"Ji","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2026.115154_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136855","article-title":"A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo","volume":"5","author":"Wu","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.115154_bib83","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400163121","article-title":"Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model","volume":"121","author":"Chang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.115154_bib84","article-title":"Analysis of Changes in Viral Load and Inflammatory Cytokines, as Well as the Occurrence of Secondary Infections","volume":"16","author":"Seo","year":"2024","journal-title":"SFTS Patients Treated with Specific Treatments: A Prospective Multicenter Cohort Study"},{"key":"10.1016\/j.isci.2026.115154_bib85","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.2147\/JIR.S478520","article-title":"Impact of Glucocorticoid Therapy on 28-Day Mortality in Patients Having Severe Fever with Thrombocytopenia Syndrome in an Intensive Care Unit: A Retrospective Analysis","volume":"17","author":"Wang","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.isci.2026.115154_bib86","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2406379","article-title":"Akkermansia in the gastrointestinal tract as a modifier of human health","volume":"16","author":"Panzetta","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.isci.2026.115154_bib87","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s42003-024-05867-6","article-title":"Akkermansia muciniphila-induced trained immune phenotype increases bacterial intracellular survival and attenuates inflammation","volume":"7","author":"Pe\u00f1a-Cearra","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2026.115154_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202101580","article-title":"Bioinspired Artificial Liver System with hiPSC-Derived Hepatocytes for Acute Liver Failure Treatment","volume":"10","author":"Wang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.isci.2026.115154_bib89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bsheal.2021.12.008","article-title":"Immunogenicity and protective efficacy of an inactivated SFTS vaccine candidate in mice","volume":"4","author":"Li","year":"2022","journal-title":"Biosafety and Health"},{"key":"10.1016\/j.isci.2026.115154_bib90","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41541-018-0096-y","article-title":"Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus","volume":"4","author":"Dong","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.115154_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/v15030800","article-title":"Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step","volume":"15","author":"Hu","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008859","article-title":"A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome","volume":"17","author":"Yoshikawa","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.115154_bib93","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3389\/fmicb.2020.01473","article-title":"Recombinant Human Adenovirus Type 5 Co-expressing RABV G and SFTSV Gn Induces Protective Immunity Against Rabies Virus and Severe Fever With Thrombocytopenia Syndrome Virus in Mice","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib94","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41541-024-00993-y","article-title":"Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice","volume":"9","author":"Qian","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.115154_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1348276","article-title":"Comparative analysis of the efficacy of vaccines using structural protein subunits of the severe fever with thrombocytopenia syndrome virus","volume":"15","author":"Kim","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib96","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01868-23","article-title":"Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of Dabie bandavirus in aged ferrets","volume":"14","author":"Kim","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.isci.2026.115154_bib97","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1038\/s41467-019-11815-4","article-title":"Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferrets","volume":"10","author":"Kwak","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115154_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007813","article-title":"Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice","volume":"14","author":"Kang","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29203","article-title":"SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge","volume":"95","author":"Kim","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.isci.2026.115154_bib100","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00769-24","article-title":"A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses","volume":"98","author":"Lu","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115154_bib101","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41541-023-00771-2","article-title":"mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice","volume":"8","author":"Kim","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.115154_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/v16010128","article-title":"Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development. Viruses 16","volume":"16","author":"Kim","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib103","article-title":"Viral Live-Attenuated Vaccines (LAVs): Past and Future Directions","volume":"12","author":"Tang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.115154_bib104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","article-title":"Engineering DNA vaccines against infectious diseases","volume":"80","author":"Lee","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.isci.2026.115154_bib105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.actbio.2024.05.050","article-title":"MIL-53(Al)-oil\/water emulsion composite as an adjuvant promotes immune responses to an inactivated pseudorabies virus vaccine in mice and pigs","volume":"183","author":"Yang","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.isci.2026.115154_bib106","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12275-024-00119-y","article-title":"Vaccine Development for Severe Fever with Thrombocytopenia Syndrome Virus in Dogs","volume":"62","author":"Park","year":"2024","journal-title":"J. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2021.109076","article-title":"A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice","volume":"257","author":"Tian","year":"2021","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.isci.2026.115154_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/v17081095","article-title":"Homologous and Heterologous Vaccination Regimens with mRNA and rVSV Platforms Induce Potent Immune Responses Against SFTSV Glycoprotein","volume":"17","author":"Manzoni","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115154_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012815","article-title":"Development of a novel multi-epitope mRNA vaccine candidate to combat SFTSV pandemic","volume":"19","author":"Zhu","year":"2025","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib110","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1093\/infdis\/jiw061","article-title":"Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study","volume":"213","author":"Dodd","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib111","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection","volume":"375","author":"PREVAIL II Writing Group","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115154_bib112","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115154_bib113","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","article-title":"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","volume":"19","author":"Modjarrad","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.115154_bib114","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2018.01.017","article-title":"Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome","volume":"101","author":"Kwon","year":"2018","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.isci.2026.115154_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105527","article-title":"Decoding broadly neutralizing antibodies: a milestone in SFTSV therapy","volume":"111","author":"Zhao","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.115154_bib116","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/JVI.02277-13","article-title":"The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha\/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever","volume":"88","author":"Liu","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.isci.2026.115154_bib117","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41541-020-00249-5","article-title":"Navigating facilitated regulatory pathways during a disease X pandemic","volume":"5","author":"Simpson","year":"2020","journal-title":"npj Vaccines"},{"key":"10.1016\/j.isci.2026.115154_bib118","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226005298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226005298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:35:15Z","timestamp":1790692515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226005298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2589004226005298"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115154","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the lethal weakness of SFTSV: Latest advances in antiviral strategies and immune prevention","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115154"}}